120 related articles for article (PubMed ID: 26545298)
1. Gender differences in the treatment of first-episode schizophrenia: Results from the European First Episode Schizophrenia Trial.
Ceskova E; Prikryl R; Libiger J; Svancara J; Jarkovsky J
Schizophr Res; 2015 Dec; 169(1-3):303-307. PubMed ID: 26545298
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).
Boter H; Peuskens J; Libiger J; Fleischhacker WW; Davidson M; Galderisi S; Kahn RS;
Schizophr Res; 2009 Dec; 115(2-3):97-103. PubMed ID: 19819114
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST).
Pijnenborg GH; Timmerman ME; Derks EM; Fleischhacker WW; Kahn RS; Aleman A
Eur Neuropsychopharmacol; 2015 Jun; 25(6):808-16. PubMed ID: 25907250
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
Volavka J; Czobor P; Derks EM; Bitter I; Libiger J; Kahn RS; Fleischhacker WW;
J Clin Psychiatry; 2011 Jul; 72(7):955-61. PubMed ID: 21824456
[TBL] [Abstract][Full Text] [Related]
5. Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST.
Rybakowski JK; Vansteelandt K; Remlinger-Molenda A; Fleischhacker WW; Kahn RS; Peuskens J;
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1500-5. PubMed ID: 25085534
[TBL] [Abstract][Full Text] [Related]
6. Treatment of depression in first episode of schizophrenia: results from EUFEST.
Rybakowski JK; Vansteelandt K; Szafranski T; Thys E; Jarema M; Wolfgang Fleischhacker W; Kahn RS; Peuskens J;
Eur Neuropsychopharmacol; 2012 Dec; 22(12):875-82. PubMed ID: 22627166
[TBL] [Abstract][Full Text] [Related]
7. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
Fleischhacker WW; Siu CO; Bodén R; Pappadopulos E; Karayal ON; Kahn RS;
Int J Neuropsychopharmacol; 2013 Jun; 16(5):987-95. PubMed ID: 23253821
[TBL] [Abstract][Full Text] [Related]
8. Interpreting treatment trials in schizophrenia patients: lessons learned from EUFEST.
Fleischhacker WW; Derks E; Kahn RS
Schizophr Res; 2012 Jun; 138(1):39-40. PubMed ID: 22542244
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE;
Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841
[TBL] [Abstract][Full Text] [Related]
10. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).
Davidson M; Galderisi S; Weiser M; Werbeloff N; Fleischhacker WW; Keefe RS; Boter H; Keet IP; Prelipceanu D; Rybakowski JK; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Kahn RS
Am J Psychiatry; 2009 Jun; 166(6):675-82. PubMed ID: 19369319
[TBL] [Abstract][Full Text] [Related]
11. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Olié JP; Spina E; Murray S; Yang R
Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
[TBL] [Abstract][Full Text] [Related]
13. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
14. The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial.
Fleischhacker WW; Keet IP; Kahn RS;
Schizophr Res; 2005 Oct; 78(2-3):147-56. PubMed ID: 16055308
[TBL] [Abstract][Full Text] [Related]
15. One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis.
San L; Arranz B; Perez V; Safont G; Corripio I; Ramirez N; Dueñas R; Alvarez E
Psychiatry Res; 2012 Dec; 200(2-3):693-701. PubMed ID: 22954905
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia: part II: the use of subscales of the PANSS score.
Pilla Reddy V; Kozielska M; Suleiman AA; Johnson M; Vermeulen A; Liu J; de Greef R; Groothuis GM; Danhof M; Proost JH
Schizophr Res; 2013 May; 146(1-3):153-61. PubMed ID: 23473811
[TBL] [Abstract][Full Text] [Related]
17. Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.
Potkin SG; Weiden PJ; Loebel AD; Warrington LE; Watsky EJ; Siu CO
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1233-48. PubMed ID: 19419595
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: a 12-week randomized, flexible-dose, open-label trial.
Crespo-Facorro B; Ortiz-García de la Foz V; Mata I; Ayesa-Arriola R; Suarez-Pinilla P; Valdizan EM; Vázquez-Barquero JL; Pérez-Iglesias R
Schizophr Res; 2013 Jul; 147(2-3):375-82. PubMed ID: 23643328
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
